Preventive intraperitoneal hyperthermic perfusion chemotherapy for patients with T4 stage colon adenocarcinoma

[1]  J. Tuynman,et al.  Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. , 2019, The lancet. Gastroenterology & hepatology.

[2]  D. Elias,et al.  Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases , 2019, Annals of Surgical Oncology.

[3]  T. de Baère,et al.  Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect? , 2018, European journal of cancer.

[4]  N. Aaronson,et al.  Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer , 2018, The New England journal of medicine.

[5]  B. Moran.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: from novelty to routine in selected cases , 2017, Techniques in Coloproctology.

[6]  D. Bartlett,et al.  Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI) , 2017, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[7]  K. Sugihara,et al.  Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis , 2016, Journal of Gastroenterology.

[8]  Andrew D. Newton,et al.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. , 2016, Journal of gastrointestinal oncology.

[9]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[10]  Y. Li,et al.  Laparoscopic colorectal resection versus open colorectal resection in octogenarians: a systematic review and meta-analysis of safety and efficacy , 2016, Techniques in Coloproctology.

[11]  V. Lemmens,et al.  Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: A systematic review. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  F. Roviello,et al.  Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results. , 2015, Critical reviews in oncology/hematology.

[13]  M. Fakih.  Metastatic colorectal cancer: current state and future directions. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Hermann Brenner,et al.  Colorectal cancer , 2014, The Lancet.

[15]  E. Chouillard,et al.  Peritoneal carcinomatosis of colorectal origin: is it really an end-stage disease? , 2013, Techniques in Coloproctology.

[16]  C. Tang,et al.  Young colorectal carcinoma patients do not have a poorer prognosis: a comparative review of 2,426 cases , 2013, Techniques in Coloproctology.

[17]  K. Kumamoto,et al.  Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy? , 2013, Techniques in Coloproctology.

[18]  K. Li,et al.  Trends in cancer mortality in China: an update. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[20]  Michael F. Flessner,et al.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence , 2010, Nature Reviews Clinical Oncology.

[21]  R. Issels.  Hyperthermia adds to chemotherapy. , 2008, European journal of cancer.

[22]  C. Ling,et al.  Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  M. Markman.  Strategies to examine new compounds for intraperitoneal use in ovarian cancer , 2008, International Journal of Gynecologic Cancer.

[24]  P. Sugarbaker,et al.  Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  P. Sugarbaker.  Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy , 2005, Techniques in Coloproctology.

[26]  Shung-Haur Yang,et al.  Risk factors for peritoneal dissemination of colorectal cancer , 2004, Journal of surgical oncology.

[27]  H. van Tinteren,et al.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  U. Metzger,et al.  Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer , 2003, The British journal of surgery.

[29]  E. Zintzaras,et al.  Incidence and Prognostic Value of Positive Peritoneal Cytology in Colorectal Cancer , 2003, Diseases of the colon and rectum.

[30]  U. Metzger,et al.  Disseminated Single Tumor Cells as Detected by Real-Time Quantitative Polymerase Chain Reaction Represent a Prognostic Factor in Patients Undergoing Surgery for Colorectal Cancer , 2002, Annals of surgery.

[31]  C. Hill,et al.  [The frequency of cancer in France: Most recent data and trends]. , 2017, Bulletin du cancer.

[32]  C. Hill,et al.  La fréquence des cancers en 2016 et leur évolution , 2017 .